Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibitory Effects of Hesperetin and EGCG in the Lung Cancer Progression involves impairment in TOP2A gene expression regulation. | Appl Biochem Biotechnol | 2025 | 41074927 | PubTator, text mining | PubMed |
| CKS2 is overexpressed in high-grade and recurrent meningiomas and functions as an oncogene via the CKS2/miR-26a/miR-101 axis. | Comput Biol Med | 2025 | 41061391 | PubTator, text mining | PubMed |
| In-silico identification of host-key-genes associated with dengue-virus-infections highlighting their pathogenetic mechanisms and therapeutic agents. | PLoS One | 2025 | 41056367 | PubTator, text mining | PubMed |
| Disulfidptosis-Associated CCNB2: A Prognostic Biomarker and Immune Microenvironment Modulator in Prostate Cancer. | J Cancer | 2025 | 41049007 | PubTator, text mining | PubMed |
| Investigating Germ Cell Transition Genes in Breast Cancer: Exploring the Genesis of Cancer Testis-Associated Markers. | Int J Mol Sci | 2025 | 41009526 | PubTator, text mining | PubMed |
| Pro-apoptotic effects of 5-fluorouracil on ameloblastoma in vitro: Exploring the potential of topical 5-FU ointment in adjunctive therapy. | J Craniomaxillofac Surg | 2025 | 40987695 | PubTator, text mining | PubMed |
| Integrated bioinformatic and experimental study links cyclin B1/B2 to poor prognosis and immune infiltration in endometrial cancer. | J Obstet Gynaecol | 2025 | 40944462 | PubTator, text mining | PubMed |
| The p400 complex promotes HIV-1 latency by suppressing viral transcription and altering the host cell state. | Nucleic Acids Res | 2025 | 40842241 | PubTator, text mining | PubMed |
| GEN1 regulates cell proliferation, migration, apoptosis and ferroptosis in gastric cancer. | World J Gastrointest Oncol | 2025 | 40837761 | PubTator, text mining | PubMed |
| Suppressive effects of Momordica charantia MAP30 on the senescence, proliferation and migration of bladder cancer cells mediated by CENPA. | Sci Rep | 2025 | 40804263 | PubTator, text mining | PubMed |
| Identification of hub genes as potential diagnostic biomarkers for cervical cancer: A bioinformatic approach. | Comput Biol Chem | 2025 | 40763562 | PubTator, text mining | PubMed |
| Inhibition of KIAA0101 Expression Can Regulate Cell Proliferation and Apoptosis in Colon Cancer. | Cancer Biother Radiopharm | 2025 | 40681332 | PubTator, text mining | PubMed |
| Expression of the IL-18-related gene PTX3 correlates with clinicopathological features and prognosis in glioma patients. | PeerJ | 2025 | 40656950 | PubTator, text mining | PubMed |
| Identification of biomarkers and exploration of mechanisms for atopic dermatitis based on transcriptome and scRNA-seq data analysis. | Medicine (Baltimore) | 2025 | 40629565 | PubTator, text mining | PubMed |
| Machine learning-assisted multi-dimensional transcriptomic analysis of cytoskeleton-related molecules and their relationship with prognosis in hepatocellular carcinoma. | Sci Rep | 2025 | 40610613 | PubTator, text mining | PubMed |
| RNA-Seq Uncovers Association of Endocrine-Disrupting Chemicals with Hub Genes and Transcription Factors in Aggressive Prostate Cancer. | Int J Mol Sci | 2025 | 40564927 | PubTator, text mining | PubMed |
| MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma. | Diagnostics (Basel) | 2025 | 40564876 | PubTator, text mining | PubMed |
| Clinical significance of cyclin-dependent kinase inhibitor 3 in hepatocellular carcinoma. | Mol Clin Oncol | 2025 | 40496041 | PubTator, text mining | PubMed |
| A novel programmed cell death signature predicts clinical outcomes in clear cell renal cell carcinoma and identifies PLK1 as a therapeutic target. | Apoptosis | 2025 | 40488834 | PubTator, text mining | PubMed |
| Noncanonical PRC1.1 targets BTG2 to retain cyclin gene expression and cell growth in neuroblastoma. | Oncogenesis | 2025 | 40461451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=4